Hilltop Holdings Inc. Vertex Pharmaceuticals Inc Transaction History

Hilltop Holdings Inc.

$1.54 Billion
Q4 2024

A detailed history of Hilltop Holdings Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hilltop Holdings Inc. holds 3,545 shares of VRTX stock, worth $1.82 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,545

Previous 3,143 12.79%

Holding current value

$1.82 Million

Previous $1.46 Million 2.33%

% of portfolio

0.09%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$396.64 - $516.74 $159,449 - $207,729	402 Added 12.79%	3,545 $1.43 Million
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $1.13 Million - $1.24 Million	2,459 Added 359.5%	3,143 $1.46 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $815 - $892	2 Added 0.29%	684 $285,000
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $3,430 - $4,106	-10 Reduced 1.45%	682 $277,000
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $3,719 - $3,987	-11 Reduced 1.56%	692 $240,000
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $2,200 - $2,463	-7 Reduced 0.99%	703 $247,000
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $566 - $646	-2 Reduced 0.28%	710 $223,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $194,966 - $217,537	712 New	712 $206,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $282,922 - $333,639	-1,509 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $312,393 - $364,136	1,509 New	1,509 $324,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $193,527 - $229,446	-757 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $170,688 - $223,920	757 New	757 $220,000
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $233,029 - $294,850	-1,534 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $257,297 - $295,663	1,534 New	1,534 $296,000

Others Institutions Holding VRTX

# of Institutions

1,764

Shares Held

228M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $132B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Holdings Inc. with notifications on news.

Account

Hilltop Holdings Inc. Vertex Pharmaceuticals Inc Transaction History